Patents by Inventor Pushkal Garg

Pushkal Garg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TUNABLE REVERSIR TM COMPOUNDS
    Publication number: 20250059536
    Abstract: The present invention relates, in general to agents that modulate the pharmacological activity of siRNAs. In addition, the invention relates generally to methods and systems for use in assessing the efficacy and safety of a pharmaceutical composition for use in the treatment or prophylaxis of a disease.
    Type: Application
    Filed: May 9, 2024
    Publication date: February 20, 2025
    Applicant: ALNYLAM PHARMACEUTICALS, INC.
    Inventors: Ivan ZLATEV, Adam CASTORENO, Martin MAIER, Vasant JADHAV, Jae KIM, Pushkal GARG
  • Tunable Reversir™ compounds
    Patent number: 12018260
    Abstract: The present invention relates, in general to agents that modulate the pharmacological activity of siRNAs. In addition, the invention relates generally to methods and systems for use in assessing the efficacy and safety of a pharmaceutical composition for use in the treatment or prophylaxis of a disease.
    Type: Grant
    Filed: January 25, 2022
    Date of Patent: June 25, 2024
    Assignee: ALNYLAM PHARMACEUTICALS, INC.
    Inventors: Ivan Zlatev, Adam Castoreno, Martin Maier, Vasant Jadhav, Jae Kim, Pushkal Garg
  • TUNABLE REVERSIR TM COMPOUNDS
    Publication number: 20230029227
    Abstract: The present invention relates, in general to agents that modulate the pharmacological activity of siRNAs. In addition, the invention relates generally to methods and systems for use in assessing the efficacy and safety of a pharmaceutical composition for use in the treatment or prophylaxis of a disease.
    Type: Application
    Filed: January 25, 2022
    Publication date: January 26, 2023
    Applicant: ALNYLAM PHARMACEUTICALS, INC.
    Inventors: Ivan ZLATEV, Adam CASTORENO, Martin MAIER, Vasant JADHAV, Jae KIM, Pushkal GARG
  • METHODS AND COMPOSITIONS FOR TREATING A SERPINC1-ASSOCIATED DISORDER
    Publication number: 20220017902
    Abstract: The invention relates to iRNA, e.g., double stranded ribonucleic acid (dsRNA), compositions targeting the Serpinc1 gene, and methods of using such iRNA, e.g., dsRNA, compositions to inhibit expression of Serpinc1 and to treat subjects having a Serpinc1-associated disease, e.g., a bleeding disorder, such as a hemophilia.
    Type: Application
    Filed: July 14, 2021
    Publication date: January 20, 2022
    Applicant: Genzyme Corporation
    Inventors: Akin Akinc, Benny Sorensen, Pushkal Garg, Gabriel Robbie
  • Methods and compositions for treating a Serpinc1-associated disorder
    Patent number: 11091759
    Abstract: The invention relates to iRNA, e.g., double stranded ribonucleic acid (dsRNA), compositions targeting the Serpinc1 gene, and methods of using such iRNA, e.g., dsRNA, compositions to inhibit expression of Serpinc1 and to treat subjects having a Serpinc1-associated disease, e.g., a bleeding disorder, such as a hemophilia.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: August 17, 2021
    Assignee: Genzyme Corporation
    Inventors: Akin Akinc, Benny Sorensen, Pushkal Garg, Gabriel Robbie
  • METHODS AND COMPOSITIONS FOR TREATING A SERPINC1-ASSOCIATED DISORDER
    Publication number: 20170159053
    Abstract: The invention relates to iRNA, e.g., double stranded ribonucleic acid (dsRNA), compositions targeting the Serpinc1 gene, and methods of using such iRNA, e.g., dsRNA, compositions to inhibit expression of Serpinc1 and to treat subjects having a Serpinc1-associated disease, e.g., a bleeding disorder, such as a hemophilia.
    Type: Application
    Filed: December 7, 2016
    Publication date: June 8, 2017
    Inventors: Akin Akinc, Benny Sorensen, Pushkal Garg, Gabriel Robbie